Equillium Inc Share Price Today: Live Updates & Key Insights
Equillium Inc share price today is $2.13, up -0.47%. The stock opened at $2.105 against the previous close of $2.14, with an intraday high of $2.2785 and low of $2.015.
Equillium Inc Share Price Chart
Equillium Inc
Equillium Inc Share Price Performance
Equillium Inc Institutional Holdings
Equillium Inc Market Status
Equillium Inc Fundamentals
Market Cap 129.70 M
PB Ratio 4.202
PE Ratio 0.0
Enterprise Value 97.63 M
Total Assets 25.60 M
Volume 661047
Equillium Inc Company Financials
About Equillium Inc & investment objective
Company Information Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and in phase 2 clinical trial for the treatment of ulcerative colitis. The company also develops EQ101, first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, which completed Phase 1/2 to treat cutaneous T cell lymphoma. It serves its products to gastroenterology, dermatology, hematology, transplant science, rheumatology, pulmonology, and oncology areas. The company has a collaboration and license agreement with Biocon SA to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Organisation Biotechnology
Employees 35
Industry Biotechnology
CEO Mr. Bruce D. Steel C.F.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Equillium Inc FAQs
What is the share price of Equillium Inc today?
The current share price of Equillium Inc is $2.13.
Can I buy Equillium Inc shares in India?
Yes, Indian investors can buy Equillium Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Equillium Inc shares in India?
You can easily invest in Equillium Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Equillium Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Equillium Inc.
Can I buy fractional shares of Equillium Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Equillium Inc?
Equillium Inc has a market cap of $129.70 M.
In which sector does Equillium Inc belong?
Equillium Inc operates in the Biotechnology sector.
What documents are required to invest in Equillium Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Equillium Inc?
The PE ratio of Equillium Inc is N/A and the PB ratio is 4.20.